0.8249
전일 마감가:
$0.8468
열려 있는:
$0.88
하루 거래량:
589.37K
Relative Volume:
0.54
시가총액:
$130.93M
수익:
-
순이익/손실:
$-41.23M
주가수익비율:
-1.1784
EPS:
-0.7
순현금흐름:
$-11.54M
1주 성능:
+1.98%
1개월 성능:
+15.39%
6개월 성능:
+26.93%
1년 성능:
-61.09%
Renovaro Inc Stock (RENB) Company Profile
명칭
Renovaro Inc
전화
45 39179840
주소
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
RENB을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RENB
Renovaro Inc
|
0.8249 | 130.93M | 0 | -41.23M | -11.54M | -0.70 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Renovaro Inc 주식(RENB)의 최신 뉴스
Renovaro (NASDAQ:RENB) Posts Earnings Results - MarketBeat
Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow
Renovaro: Fiscal Q2 Earnings Snapshot - CTPost
Renovaro: Fiscal Q2 Earnings Snapshot -February 19, 2025 at 05:03 pm EST - Marketscreener.com
RENOVARO INC. SEC 10-Q Report - TradingView
Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows - Marketscreener.com
This AI Stock Is Up 50% in 2025. Is It Too Late to Buy? - The Globe and Mail
SG Americas Securities LLC Boosts Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro (NASDAQ:RENB) Stock Quotes, Forecast and News Summary - Benzinga
AMC Networks (AMCX) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Renovaro Biosciences Updates CEO Compensation Plan - TipRanks
Renovaro Inc (RENB)’s Market Momentum: Closing Strong at 0.70, Up 4.32 - The Dwinnex
RENB (Renovaro Inc) may reap gains as insiders became active recently - Knox Daily
After Falling -6.53% During The Past Week, Should You Still Buy Renovaro Inc (NASDAQ: RENB)? - Marketing Sentinel
Sagimet Biosciences Inc (NASDAQ:SGMT) Up 47.7% Since 52-Week Low; YTD Rose 1.56% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel
Renovaro Inc (RENB) Stock: From Low to High in 52 Weeks - The InvestChronicle
Renovaro Inc. (NASDAQ:RENB) Stock Holdings Increased by JPMorgan Chase & Co. - Defense World
Quarterly Snapshot: Quick and Current Ratios for Renovaro Inc (RENB) - The Dwinnex
Renovaro Inc (RENB)’s results reveal risk - US Post News
Barclays PLC Has $34,000 Stock Position in Renovaro Inc. (NASDAQ:RENB) - Defense World
Short Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7% - MarketBeat
Renovaro Inc. appoints new CFO Nathen Fuentes - Investing.com India
Renovaro Inc. appoints new CFO Nathen Fuentes By Investing.com - Investing.com South Africa
Geode Capital Management LLC Decreases Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Renovaro To Buy Predictive Oncology in All-Stock Deal - Pulse 2.0
Renovaro Biosciences Subsidiary Appoints New CEO - MSN
Renovaro appoints Nathen Fuentes as finance chief - MSN
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve
Renovaro Biosciences Merges with Predictive Oncology - MSN
PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Marketscreener.com
Renovaro Inc. appoints new CEO for subsidiary By Investing.com - Investing.com Australia
Nathen Fuentes Joins Renovaro as Chief Financial Officer - citybiz
Renovaro BioSciences issues shareholder letter, provides corporate update - TipRanks
Renovaro Taps Nathen Fuentes as Finance Chief - MarketWatch
Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times
Renovaro Inc. appoints new CEO for subsidiary - Investing.com
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders - GlobeNewswire
Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0
Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead
Renovaro to Acquire Predictive Oncology - citybiz
M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant
POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire
Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times
Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch
Renovaro to Acquire Predictive Oncology in All-Stock Transaction - Benzinga
Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire
Renovaro Inc (RENB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Renovaro Inc 주식 (RENB) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
William Anderson Wittekind | 10% Owner |
Jul 17 '24 |
Sale |
1.46 |
16,362 |
23,889 |
841,433 |
William Anderson Wittekind | 10% Owner |
Jul 15 '24 |
Sale |
1.41 |
21,954 |
30,955 |
875,795 |
William Anderson Wittekind | 10% Owner |
Jul 10 '24 |
Sale |
1.51 |
75,000 |
113,250 |
894,645 |
William Anderson Wittekind | 10% Owner |
Jul 11 '24 |
Sale |
1.51 |
14,896 |
22,493 |
897,749 |
William Anderson Wittekind | 10% Owner |
Jul 09 '24 |
Sale |
1.53 |
4,630 |
7,084 |
969,645 |
William Anderson Wittekind | 10% Owner |
Jul 05 '24 |
Sale |
1.55 |
60,000 |
93,000 |
974,275 |
William Anderson Wittekind | 10% Owner |
Jul 03 '24 |
Sale |
1.51 |
50,000 |
75,500 |
1,034,275 |
William Anderson Wittekind | 10% Owner |
Jul 01 '24 |
Sale |
1.56 |
60,000 |
93,600 |
1,118,828 |
William Anderson Wittekind | 10% Owner |
Jul 02 '24 |
Sale |
1.54 |
34,553 |
53,212 |
1,084,275 |
William Anderson Wittekind | 10% Owner |
Jun 26 '24 |
Sale |
1.57 |
50,000 |
78,500 |
1,193,499 |
자본화:
|
볼륨(24시간):